1
|
F
|
British
|
ODG, low grade early, later *AO
|
25
|
Cervical lymph nodes, scalp, lung, bone
|
84
|
*
|
*
|
James et al. 1951 [26]
|
2
|
F
|
American
|
ODG, *grade
|
7
|
Scalp, bone, soft tissue, liver
|
36
|
*
|
*
|
Spataro et al. 1968 [27]
|
3
|
F
|
Austrian
|
ODG, *grade
|
58
|
Bone
|
30
|
*
|
*
|
Jellinger et al. 1969 [28], (also reported as Schuster et al. 1976 [29])
|
4
|
M
|
American
|
*ODG, *grade
|
45
|
Bone marrow
|
17
|
*
|
*
|
Smith et al. 1969 [2]
|
5
|
*
|
*
|
ODG, initially low grade
|
3.5
|
Lymph nodes, lungs, adrenal
|
21
|
*
|
*
|
Kernohan 1971 [30]
|
6
|
F
|
Scottish
|
Malignant glioma, some ODG features
|
21
|
Bone
|
9
|
*
|
*
|
Eade et al. 1971 [31]
|
7
|
M
|
Scottish
|
Small cell GBM with regions of ODG
|
23
|
Bone
|
12
|
*
|
*
| |
8
|
M
|
French
|
*ODG, *grade
|
57
|
Lymph nodes, bone
|
20
|
*
|
*
|
Cappellaere et al. 1972 [32]
|
9
|
M
|
French
|
*ODG, *grade
|
22
|
Lymph nodes, bone, parotid gland
|
25
|
*
|
*
| |
10
|
F
|
British
|
Malignant glioma, some ODG features
|
30
|
Pleura
|
156
|
*
|
*
|
Brander et al. 1975 [33]
|
11
|
M
|
German
|
*ODG, *grade
|
40
|
Bone, lymph nodes, lungs
|
86
|
*
|
*
|
Kummer et al. 1977 [34]
|
12
|
*
|
Canadian
|
*ODG, *grade
|
*
|
Scalp
|
*
|
*
|
*
|
Chin et al. 1980 [35]
|
13
|
F
|
American
|
ODG, grade II
|
33
|
Bone, lymph nodes, scalp, soft tissue
|
50
|
*
|
*
|
Ordonez et al. 1981 [36]
|
14
|
M
|
Japanese
|
Grade III
|
32
|
Bone
|
76
|
14
|
*
|
Nakamura et al. 1985 [37]
|
15
|
M
|
*
|
ODG, malignant
|
41
|
Bone marrow
|
48
|
*
|
*
|
Newman et al. 1985 [38]
|
16
|
*
|
Canadian
|
ODG, *grade, some astro
|
12
|
Bone, lymph nodes, scalp
|
104
|
*
|
*
|
Macdonald et al. 1989 [39]
|
17
|
*
|
Canadian
|
ODG, *grade
|
44
|
Cervical lymph nodes, bone,
|
48
|
*
|
*
| |
18
|
F
|
Canadian
|
ODG, grade III
|
36
|
Bone, lymph nodes
|
60
|
*
|
*
| |
19
|
*
|
Canadian
|
ODG, *grade, some astro
|
32
|
Bone, lymph nodes, scalp
|
38
|
*
|
*
| |
20
|
*
|
Canadian
|
ODG, *grade
|
34
|
Bone
|
76+
|
*
|
*
| |
21
|
M
|
Canadian
|
ODG, grade III
|
27
|
Bone
|
37
|
*
|
*
| |
22
|
*
|
Canadian
|
ODG, *grade, some astro
|
47
|
Bone
|
26+
|
*
|
*
| |
23
|
*
|
Polish
|
Grade III
|
*
|
*
|
*
|
*
|
*
|
Rolski et al. 1993 [40]
|
24
|
*
|
German
|
*
|
*
|
Cervical lymph nodes
|
*
|
*
|
*
|
Steininger et al. 1993 [41]
|
25
|
M
|
British
|
ODG, grade III
|
54
|
Bone marrow
|
12
|
*
|
*
|
Gerrard et al. 1995 [42]
|
26
|
*
|
German
|
Grade III
|
*
|
Cervical lymph nodes
|
*
|
48
|
*
|
Schroder et al. 1995 [43]
|
27
|
M
|
Italian
|
ODG, grade II
|
58
|
Chest wall, bone marrow, possibly liver
|
48
|
*
|
*
|
Monzani et al. 1996 [44]
|
28
|
M
|
British
|
ODG, grade III
|
43
|
Bone marrow, liver
|
3
|
*
|
*
|
Dawson 1997 [45]
|
29
|
M
|
Austrian
|
ODG-astrocytoma grade III
|
62
|
Thoracic wall, pleura, bone marrow
|
288
|
6
|
*
|
Finsterer et al. 1998 [46]
|
30
|
M
|
Indian
|
Grade III
|
50
|
Bone and bone marrow
|
7+
|
*
|
*
|
Anand et al. 2001 [47]
|
31
|
*
|
Italian
|
ODG, grade II
|
25
|
Bone
|
84+
|
*
|
*
|
Giordana et al. 2002 [48]
|
32
|
M
|
Indian
|
Grade III
|
50
|
Bone marrow
|
17
|
*
|
*
|
Sharma et al. 2003 [49]
|
33
|
M
|
American
|
Grade III
|
33
|
Bone marrow
|
38+
|
*
|
*
|
Choon et al. 2004 [50]
|
34
|
M
|
Canadian
|
Grade III
|
35
|
Bone
|
84
|
23
|
Allelic LOH of chromosome 1p (1p-), a rise in serum alkaline phosphatase
|
Morrison et al. 2004 [51]
|
35
|
F
|
American
|
ODG, grade II early, later AO, grade III
|
41
|
Parotid gland
|
79+
|
68
|
Codeletion of 1p/19q
|
Wang et al. 2004 [52]
|
36
|
M
|
American
|
ODG, low grade early, later AO, grade III
|
28
|
Bone marrow
|
120
|
5
|
Positive for S-100 marker with immunohistochemical stain
|
Al-Ali et al. 2005 [23]
|
37
|
M
|
American
|
Atypical meningioma, early, later AO, grade III
|
32
|
Bone, bone marrow, cervical and thoracic lesions
|
168
|
27
|
Elevated serum lactate dehydrogenase and alkaline phosphatase, positive for S-100, and GFAP with immunohistochemical stain
|
Merrell et al. 2006 [53]
|
38
|
F
|
American
|
AO, grade III
|
71
|
Bone, bone marrow,
|
17
|
13
|
Codeletion of 1p/19q, positive for S-100, and GFAP with immunohistochemical stain, elevated serum hemoglobin level
| |
39
|
F
|
Chinese
|
ODG, *grade
|
64
|
Pleura, bone
|
*
|
84
|
Positive for S-100, Olig2 and GFAP with immunohistochemical stain
|
Lee et al. 2006 [54]
|
40
|
M
|
American
|
ODG, grade II early, later AO, grade III
|
15
|
Pleura, bone, lungs, adrenal gland, chest, liver, abdomen
|
62
|
31
|
Codeletion of 1p/19q
|
Bruggers et al. 2007 [55]
|
41
|
F
|
Japanese
|
AO, grade III
|
17
|
Spleen, liver, pancreas, bone, spinal dura mater, dorsal root ganglia, lungs, lymph nodes, iliopsoas muscle
|
144
|
3
|
Markedly positive for Ki-67, and positive for Olig2 with immunohistochemical stain,
|
Uzuka et al. 2007 [56]
|
42
|
F
|
Korean
|
AO, grade III
|
48
|
Liver, lungs
|
28
|
27
|
Not presented
|
Han et al. 2008 [4]
|
43
|
M
|
Italian
|
AO, grade III
|
40
|
Bone, bone marrow, liver
|
10
|
5
|
Not presented
|
Zustovich et al. 2008 [57]
|
44
|
F
|
Slovenian
|
AO, grade III
|
54
|
Cervical and neck lymph nodes
|
48
|
12
|
Positive for S-100, and GFAP with immunohistochemical stain
|
Volavsek et al. 2009 [58]
|
45
|
F
|
Slovenian
|
AOA, grade III
|
30
|
Bone
|
58+
|
17
|
Positive for GFAP with immunohistochemical stain
| |
46
|
M
|
Japanese
|
AO, grade III
|
53
|
Lymph nodes, bone, spinal dura mater, thymus gland, chest wall
|
30
|
24
|
Codeletion of 1p/19q
|
Noshita N, et al. 2010 [59]
|
47
|
F
|
Japanese
|
AO, grade III
|
73
|
Cervical lesion
|
18+
|
18
|
*
|
Oshiro S, et al. 2010 [60]
|
48
|
M
|
Dutch
|
AO, grade III
|
59
|
Bone marrow
|
33
|
31
|
Codeletion of 1p/19q, positive for S-100, and p53 with immunohistochemical stain
|
Krijnen JL, et al. 2010 [61]
|
49
|
M
|
Dutch
|
*ODG, *grade
|
24
|
Bone marrow
|
*
|
84
|
Not presented
| |
50
|
M
|
Dutch
|
AO, grade III
|
34
|
Cervical lymph nodes, iliopsoas muscle
|
*
|
not presented
|
Not presented
| |
51
|
M
|
Dutch
|
AO, grade III
|
64
|
Axillary lymph nodes
|
*
|
34
|
Not presented
| |
52
|
M
|
Dutch
|
AO, grade III
|
72
|
Bone marrow
|
*
|
6
|
Not presented
| |
53
|
F
|
Dutch
|
*ODG, *grade
|
67
|
Bone marrow
|
*
|
29
|
Not presented
| |
54
|
M
|
Dutch
|
AO, grade III
|
62
|
Retroperitoneal lymph nodes
|
*
|
21
|
Not presented
| |
55
|
M
|
Turkish
|
AO, grade III
|
55
|
Bone marrow
|
23+
|
11
|
Positive for GFAP with immunohistochemical stain
|
Kural C, et al. 2011 [62]
|
56
|
M
|
Chinese
|
AO, grade III
|
37
|
Bone
|
58+
|
37
|
Positive for S-100, and GFAP with immunohistochemical stain
|
Wu Y, et al. 2011 [63]
|
57
|
M
|
Italian
|
AO, grade III
|
40
|
Bone marrow
|
61
|
57
|
Positive for enolase, and GFAP with immunohistochemical stain
|
Cordiano V, et al. 2012 [64]
|
58
|
F
|
Turkish
|
ODG, *grade
|
*
|
Cervical lymphatic chain
|
*
|
60
|
Codeletion of 1p/19q
|
Can B, et al. 2012 [65]
|
59
|
M
|
Turkish
|
AO, grade III
|
58
|
Breast
|
*
|
*
|
*
|
Alacacioglu A, et al. 2012 [66]
|
60
|
M
|
Irish
|
AO, grade III
|
58
|
Bone
|
120+
|
108
|
Codeletion of 1p/19q, positive for GFAP with immunohistochemical stain
|
Greene J, et al. 2013 [67]
|
61
|
M
|
Chinese
|
AO, grade III
|
45
|
Bone, bone marrow, lymph nodes
|
16
|
13
|
No deletion of 1p/ 19q, PTEN mutation in exon 2, MGMT promoter methylated, positive for IDH1, Ki-67, Olig2, and GFAP, negative for MGMT, EMA and Vim with immunohistochemical stain
|
Present case
|